Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toby M Maher

Showing results (101-110 of 391) with videos related to

Pageof 40
Sort By:
Physics in Medicine and Biology|September 10, 2015
Improved correction for the tissue fraction effect in lung PET/CT imagingBeverley F Holman, Vesna Cuplov, Lynn Millner, et al.
Nature Reviews. Drug Discovery|March 19, 2025
Fibrosis: cross-organ biology and pathways to development of innovative drugsFlorian Rieder, Laura E Nagy, Toby M Maher, et al.
The Lancet. Respiratory Medicine|May 19, 2020
Pulmonary fibrosis secondary to COVID-19: a call to arms?Paolo Spagnolo, Elisabetta Balestro, Stefano Aliberti, et al.
Advances in Therapy|May 16, 2022
Meta-Analysis of Effect of Nintedanib on Reducing FVC Decline Across Interstitial Lung DiseasesFrancesco Bonella, Vincent Cottin, Claudia Valenzuela, et al.
Advances in Therapy|April 23, 2020
Healthcare Resource Utilization Among Patients in England with Systemic Sclerosis-Associated Interstitial Lung Disease: A Retrospective Database AnalysisAlicia Gayle, Nils Schoof, Margarida Alves, et al.
Nature Reviews. Drug Discovery|March 31, 2025
Publisher Correction: Fibrosis: cross-organ biology and pathways to development of innovative drugsFlorian Rieder, Laura E Nagy, Toby M Maher, et al.
Respiration; International Review of Thoracic Diseases|August 17, 2018
Identifying Barriers to Idiopathic Pulmonary Fibrosis Treatment: A Survey of Patient and Physician ViewsToby M Maher, Jeffrey J Swigris, Michael Kreuter, et al.
ERJ Open Research|March 18, 2026
A phase 1 pharmacokinetics study of deupirfenidone (LYT-100) in healthy older adultsToby M Maher, Michael C Chen, Chris C Korth, et al.
Chest|April 9, 2020
Diagnostic and Prognostic Biomarkers for Chronic Fibrosing Interstitial Lung Diseases With a Progressive PhenotypeYoshikazu Inoue, Robert J Kaner, Julien Guiot, et al.
Respiratory Research|July 25, 2020
The need for a holistic approach for SSc-ILD - achievements and ambiguity in a devastating diseaseAnna-Maria Hoffmann-Vold, Yannick Allanore, Elisabeth Bendstrup, et al.
Pageof 40

Showing results (101-110 of 391) with videos related to

Sort By:
Pageof 40
Physics in Medicine and Biology|September 10, 2015
Improved correction for the tissue fraction effect in lung PET/CT imagingBeverley F Holman, Vesna Cuplov, Lynn Millner, et al.
Nature Reviews. Drug Discovery|March 19, 2025
Fibrosis: cross-organ biology and pathways to development of innovative drugsFlorian Rieder, Laura E Nagy, Toby M Maher, et al.
The Lancet. Respiratory Medicine|May 19, 2020
Pulmonary fibrosis secondary to COVID-19: a call to arms?Paolo Spagnolo, Elisabetta Balestro, Stefano Aliberti, et al.
Advances in Therapy|May 16, 2022
Meta-Analysis of Effect of Nintedanib on Reducing FVC Decline Across Interstitial Lung DiseasesFrancesco Bonella, Vincent Cottin, Claudia Valenzuela, et al.
Advances in Therapy|April 23, 2020
Healthcare Resource Utilization Among Patients in England with Systemic Sclerosis-Associated Interstitial Lung Disease: A Retrospective Database AnalysisAlicia Gayle, Nils Schoof, Margarida Alves, et al.
Nature Reviews. Drug Discovery|March 31, 2025
Publisher Correction: Fibrosis: cross-organ biology and pathways to development of innovative drugsFlorian Rieder, Laura E Nagy, Toby M Maher, et al.
Respiration; International Review of Thoracic Diseases|August 17, 2018
Identifying Barriers to Idiopathic Pulmonary Fibrosis Treatment: A Survey of Patient and Physician ViewsToby M Maher, Jeffrey J Swigris, Michael Kreuter, et al.
ERJ Open Research|March 18, 2026
A phase 1 pharmacokinetics study of deupirfenidone (LYT-100) in healthy older adultsToby M Maher, Michael C Chen, Chris C Korth, et al.
Chest|April 9, 2020
Diagnostic and Prognostic Biomarkers for Chronic Fibrosing Interstitial Lung Diseases With a Progressive PhenotypeYoshikazu Inoue, Robert J Kaner, Julien Guiot, et al.
Respiratory Research|July 25, 2020
The need for a holistic approach for SSc-ILD - achievements and ambiguity in a devastating diseaseAnna-Maria Hoffmann-Vold, Yannick Allanore, Elisabeth Bendstrup, et al.
Pageof 40